Assyro AI

FDA Orange Book · active-ingredient family

Calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate

Calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate is approved as 3 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:BSS · NDA 020742

3

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, solution

ProductApplicantApplicationTEApproved
BSSRLDALCONNDA 020742ATDec 10, 1997
ISOLYTE E IN PLASTIC CONTAINERB BRAUNNDA 019718Sep 29, 1989
ISOLYTE E IN PLASTIC CONTAINERB BRAUNNDA 018899Oct 31, 1983

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
BALANCED SALTB BRAUNANDA 091387ATFeb 03, 2010
BALANCED SALTEPIC PHARMA LLCANDA 075503Sep 27, 2006

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.